breast cancer
Showing NaN - NaN of 217
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Breast Cancer Trial in United Kingdom (AZD4547 / anastrozole or letrozole)
Completed
- Breast Cancer
- AZD4547 / anastrozole or letrozole
-
Burton-on-Trent, Staffs, United Kingdom
- +6 more
Apr 20, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)
Active, not recruiting
- Melanoma
- +9 more
- MRx0518 Capsules
- MRx0518/placebo Capsules
-
London, United KingdomImperial College Healthcare NHS Trust
Aug 10, 2022
Histolog Comparison to Standard Histology
Active, not recruiting
- Margins of Excision
- Breast Cancer
- Histolog Scanner
-
London, United KingdomImperial College NHS Trust
Aug 9, 2022
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022
Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)
Active, not recruiting
- Carcinoma, Ductal, Breast
- +2 more
-
Sofia, Bulgaria
- +7 more
Aug 1, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer Trial in United Kingdom (zoledronic acid, quality-of-life
Terminated
- Breast Cancer
- +4 more
- zoledronic acid
- quality-of-life assessment
-
Bournemouth, England, United Kingdom
- +29 more
May 23, 2022
Breast Cancer Trial in London (Radiotherapy before surgery)
Completed
- Breast Cancer
- Radiotherapy before surgery
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 26, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022
Breast Cancer, Surgical Site Infection, Wound Dehiscence Trial in London (Negative Pressure Wound Therapy)
Not yet recruiting
- Breast Cancer
- +2 more
- Negative Pressure Wound Therapy
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 20, 2022
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Recruiting
- Breast Cancer
- +10 more
-
Hamilton, Ontario, Canada
- +6 more
Apr 21, 2022